Page last updated: 2024-11-05

thalidomide and Cerebral Cryptococcosis

thalidomide has been researched along with Cerebral Cryptococcosis in 4 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research Excerpts

ExcerptRelevanceReference
"Management of relapsing or refractory immune reconstitution inflammatory syndromes (IRISs) despite corticosteroid therapy is yet to be defined."1.38Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS. ( Brunel, AS; Le Moing, V; Lortholary, O; Makinson, A; Montes, B; Reynes, J; Rubbo, PA; Tuaillon, E, 2012)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Qin, BE1
Yuan, D1
Xu, XF1
Su, Z1
Gu, M1
Dai, K1
Peng, FH1
Jiang, Y1
Kwon, HY1
Han, YJ1
Im, JH1
Baek, JH1
Lee, JS1
Balasko, A1
Keynan, Y1
Brunel, AS1
Reynes, J1
Tuaillon, E1
Rubbo, PA1
Lortholary, O1
Montes, B1
Le Moing, V1
Makinson, A1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study[NCT04273529]Phase 2100 participants (Anticipated)Interventional2020-02-20Not yet recruiting
The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe New Coronavirus (COVID-19) Pneumonia: a Prospective, Multicenter, Randomized, Double-blind, Placebo, Parallel Controlled Clinical Study[NCT04273581]Phase 240 participants (Anticipated)Interventional2020-02-18Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for thalidomide and Cerebral Cryptococcosis

ArticleYear
Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals.
    HIV medicine, 2019, Volume: 20, Issue:1

    Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Clinical Tri

2019

Other Studies

3 other studies available for thalidomide and Cerebral Cryptococcosis

ArticleYear
Neurological worsening during treatment of HIV-negative cryptococcal meningitis in a patient with Evans syndrome.
    Future microbiology, 2023, Volume: 18

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution In

2023
Two cases of immune reconstitution inflammatory syndrome in HIV patients treated with thalidomide.
    International journal of STD & AIDS, 2019, Volume: 30, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain Edema; Do

2019
Two cases of immune reconstitution inflammatory syndrome in HIV patients treated with thalidomide.
    International journal of STD & AIDS, 2019, Volume: 30, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain Edema; Do

2019
Two cases of immune reconstitution inflammatory syndrome in HIV patients treated with thalidomide.
    International journal of STD & AIDS, 2019, Volume: 30, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain Edema; Do

2019
Two cases of immune reconstitution inflammatory syndrome in HIV patients treated with thalidomide.
    International journal of STD & AIDS, 2019, Volume: 30, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Brain Edema; Do

2019
Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS.
    AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral The

2012